HXTC-901

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHXTC-901
Drug Alias Nameplatelet substitute 2 (Haemostatix)HXTC-901
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet aggregation modulators
TargetsUpdating
Therapy Area/IndicationsHemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHaemostatix Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHaemostatix Ltd
Active IndicationsN/A
Inactive IndicationsHemorrhage

Other Information

ATC CodeN/A
Related LinksN/A